Patent details

Basic Information

Publication number:

EP1542700

PCT Application Number:

PCT/EP/2003/010239

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP037505468

PCT Publication Number:

WO/2004/024166

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ZOLEDRONIC ACID FOR PREVENTING OR REDUCING SECONDARY FRACTURES AFTER HIP FRACTURE

French Title of Invention:

L'ACIDE ZOLEDRONIQUE POUR LA PREVENTION OU LA REDUCTION DE FRACTURES SECONDAIRES CONSECUTIVES A UNE FRACTURE DE LA HANCHE

German Title of Invention:

ZOLEDRONSÄURE ZUR PRÄVENTION ODER VERMINDERUNG VON SEKUNDÄRFRAKTUREN NACH HÜFTFRAKTUR

SPC Number:

Dates

Filing date:

15/09/2003

Grant date:

09/11/2011

EP Publication Date:

09/11/2011

PCT Publication Date:

25/03/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/06/2005

EP B1 Publication Date:

09/11/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/09/2023

Renunciation date:

Revocation date:

15/09/2012

Annulment date:

Owner

From:

15/09/2003

 

 

Name:

Lyles Kenneth W.

Address:

3515 Cottonwood Drive, Durham, NC 27707, United States (US)

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

HOROWITZ Zebulun, David

Address:

United States (US)

2

Name:

LYLES Kenneth, W.

Address:

United States (US)

Priority

Priority Number:

411067 P

Priority Date:

16/09/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/675;

Filing date	Document type	Number of pages